This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy
Kari Loeser, Esq. is senior corporate counsel and senior director in the Legal & Compliance department at Jazz Pharmaceuticals plc. In this role, she oversees and conducts all US and global internal investigations and has advised client groups on a variety of legal and compliance matters pertaining to sales, marketing, and promotional matters for the Oncology portfolio; medical affairs including clinical/research, publications, and health economic outcomes research; and managed care and reimbursement activities. She also managed a team responsible for federal/state aggregate spend reporting (transparency) and compliance field monitoring. Prior to Jazz, Kari worked in medical affairs and healthcare compliance at Genentech, a member of the Roche Group. She has published various articles and a book chapter on E-Health and Ethics, and she has presented at various conferences, including the AHLA-HCCA Fraud and Abuse Conference. She is currently authoring a book chapter in CANCER POLICY: PHARMACEUTICAL SAFETY entitled “Anatomy of Risk Evaluation and Mitigation Strategies (REMS)” by Springer Publishing (Germany) with a proposed publication and release date in 2017. She is a licensed attorney, and is certified in Healthcare Compliance. She received her JD from DePaul University College of Law, and her BA with Honors from the University of Iowa.